These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9829759)
1. Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen. Conry RM; White SA; Fultz PN; Khazaeli MB; Strong TV; Allen KO; Barlow DL; Moore SE; Coan PN; Davis I; Curiel DT; LoBuglio AF Clin Cancer Res; 1998 Nov; 4(11):2903-12. PubMed ID: 9829759 [TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients. Conry RM; Curiel DT; Strong TV; Moore SE; Allen KO; Barlow DL; Shaw DR; LoBuglio AF Clin Cancer Res; 2002 Sep; 8(9):2782-7. PubMed ID: 12231517 [TBL] [Abstract][Full Text] [Related]
3. Induction of anti-tumor immunity by intrasplenic administration of a carcinoembryonic antigen DNA vaccine. White SA; LoBuglio AF; Arani RB; Pike MJ; Moore SE; Barlow DL; Conry RM J Gene Med; 2000; 2(2):135-40. PubMed ID: 10809147 [TBL] [Abstract][Full Text] [Related]
6. Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration. Conry RM; Khazaeli MB; Saleh MN; Allen KO; Barlow DL; Moore SE; Craig D; Arani RB; Schlom J; LoBuglio AF Clin Cancer Res; 1999 Sep; 5(9):2330-7. PubMed ID: 10499601 [TBL] [Abstract][Full Text] [Related]
7. Induction of immune responses and safety profiles in rhesus macaques immunized with a DNA vaccine expressing human prostate specific antigen. Kim JJ; Yang JS; Nottingham LK; Tang W; Dang K; Manson KH; Wyand MS; Wilson DM; Weiner DB Oncogene; 2001 Jul; 20(33):4497-506. PubMed ID: 11494145 [TBL] [Abstract][Full Text] [Related]
8. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen. Bråve A; Hallengärd D; Gudmundsdotter L; Stout R; Walters R; Wahren B; Hallermalm K Vaccine; 2009 Jun; 27(28):3692-6. PubMed ID: 19428161 [TBL] [Abstract][Full Text] [Related]
9. A carcinoembryonic antigen polynucleotide vaccine for human clinical use. Conry RM; LoBuglio AF; Loechel F; Moore SE; Sumerel LA; Barlow DL; Pike J; Curiel DT Cancer Gene Ther; 1995 Mar; 2(1):33-8. PubMed ID: 7621253 [TBL] [Abstract][Full Text] [Related]
10. Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus. Kass E; Schlom J; Thompson J; Guadagni F; Graziano P; Greiner JW Cancer Res; 1999 Feb; 59(3):676-83. PubMed ID: 9973217 [TBL] [Abstract][Full Text] [Related]
11. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity. Aarts WM; Schlom J; Hodge JW Cancer Res; 2002 Oct; 62(20):5770-7. PubMed ID: 12384537 [TBL] [Abstract][Full Text] [Related]
12. Humoral and cellular immune responses of dogs immunized with a nucleic acid vaccine encoding human carcinoembryonic antigen. Smith BF; Baker HJ; Curiel DT; Jiang W; Conry RM Gene Ther; 1998 Jul; 5(7):865-8. PubMed ID: 9813656 [TBL] [Abstract][Full Text] [Related]
13. Cationic transfersomes based topical genetic vaccine against hepatitis B. Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015 [TBL] [Abstract][Full Text] [Related]
14. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes. Durántez M; López-Vázquez AB; de Cerio AL; Huarte E; Casares N; Prieto J; Borrás-Cuesta F; Lasarte JJ; Sarobe P Scand J Immunol; 2009 Feb; 69(2):80-9. PubMed ID: 19144076 [TBL] [Abstract][Full Text] [Related]
15. A DNA vaccine encoding genetic fusions of carcinoembryonic antigen (CEA) and granulocyte/macrophage colony-stimulating factor (GM-CSF). Lima J; Jenkins C; Guerrero A; Triozzi PL; Shaw DR; Strong TV Vaccine; 2005 Jan; 23(10):1273-83. PubMed ID: 15652670 [TBL] [Abstract][Full Text] [Related]
16. DNA-Based immunization produces Th1 immune responses to hepatitis delta virus in a mouse model. Huang YH; Wu JC; Tao MH; Syu WJ; Hsu SC; Chi WK; Chang FY; Lee SD Hepatology; 2000 Jul; 32(1):104-10. PubMed ID: 10869296 [TBL] [Abstract][Full Text] [Related]
17. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant. Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475 [TBL] [Abstract][Full Text] [Related]
18. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen. Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612 [TBL] [Abstract][Full Text] [Related]
19. IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice. Song K; Chang Y; Prud'homme GJ Gene Ther; 2000 Sep; 7(18):1527-35. PubMed ID: 11021590 [TBL] [Abstract][Full Text] [Related]
20. A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep. Babiuk S; Tsang C; van Drunen Littel-van den Hurk S; Babiuk LA; Griebel PJ Bioelectrochemistry; 2007 May; 70(2):269-74. PubMed ID: 17118714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]